Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Cas No. | 1096708-71-2 |
---|---|
Purity | ≥98% |
Formula | C17H12Cl2F3N7O2S |
Formula Wt. | 506.30 |
IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
http://clinicaltrials.gov/show/NCT01425008
For use in amino acid analysis.
Nucleoside (cytidine) analog; RT and telomerase...
Rapamycin analog
Steroid; AR antagonist.
Anti-tuberculosis
Aminopropyl carbazole, neuroprotective.
Inhibitor of Akt.
Ras inhibitor.
Inhibitor of Bcl-2 and Bcl-xL
Macrolide; peptidyl transferase inhibitor, prot...
Pt-based DNA cross-linker.
Mycotoxin produced by Fusarium; ER agonist.
Used for in vitro fertilization; FIASMA, SERM.<...
Endogenous bombesin-related peptide, involved i...
GABA derivative; GABA-B agonist.
JAK3 inhibitor.
Non-endogenous essential vitamin (B9), found in...
mTOR inhibitor.
α2-adrenergic and imidazoline-1 antagonist, AT...
ERK1/2 inhibitor.